Urinary liver-type fatty acid-binding protein level as a predictive biomarker of contrast-induced acute kidney injury

European Journal of Clinical Investigation

Volumn 42, Issue 5, 2012, Pages 557-563

  Manabe, Kenichi ^a   Kamihata, Hiroshi ^a   Motohiro, Masayuki ^a   Senoo, Takeshi ^a   Yoshida, Susumu ^a   Iwasaka, Toshiji ^a  

^a KANSAI MEDICAL UNIVERSITY HOSPITAL   (Japan)

Author keywords

Chronic kidney disease; Contrast induced acute kidney injury; Tubulointerstitial marker

Indexed keywords

BETA 2 MICROGLOBULIN; CREATININE; FATTY ACID BINDING PROTEIN; IOPAMIDOL; LIVER TYPE FATTY ACID BINDING PROTEIN; N ACETYL BETA GLUCOSAMINIDASE; UNCLASSIFIED DRUG;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; CATHETERIZATION; CONTRAST INDUCED ACUTE KIDNEY INJURY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE MARKER; DRUG SAFETY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; RADIATION EXPOSURE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

ACUTE KIDNEY INJURY; AGED; BIOLOGICAL MARKERS; CARDIAC SURGICAL PROCEDURES; CONTRAST MEDIA; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TUBULES, PROXIMAL; MALE; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS;

EID: 84859698312     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2011.02620.x     Document Type: Article

References (26)

1. Tepel M, Aspelin P, Lameire N. Contrast-induced nephropathy: a clinical and evidence-based approach. Circulation 2006;113:1799-806.
2. Best PJ, Lennon R, Ting HH, Bell MR, Rihal CS, Holmes DR, Berger PB. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 2002;39:1113-9.
3. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 2002;39:930-6.
4. McCullough P. Outcomes of contrast-induced nephropathy: experience in patients undergoing cardiovascular intervention. Catheter Cardiovasc Interv 2006;67:335-43.
5. McCullough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol 2008;51:1419-28.
6. Solomon R, Deray G; Consensus Panel for CIN. How to prevent contrast-induced nephropathy and manage risk patients: practical recommendations. Kidney Int Suppl 2006;100:S51-3.
7. Solomon R, Barrett B. Follow-up of patients with contrast-induced nephropathy. Kidney Int Suppl 2006;100:S46-50.
8. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002;105:2259-64.
9. Veerkamp JH, Peeters RA, Maatman RG. Structural and functional features of different types of cytoplasmic fatty acid-binding proteins. Biochim Biophys Acta 1991;1081:1-24.
10. Yokoyama T, Kamijo-Ikemori A, Sugaya T, Hoshino S, Yasuda T, Kimura K. Urinary excretion of liver type fatty acid binding protein accurately reflects the degree of tubulointerstitial damage. Am J Pathol 2009;174:2096-106.
11. Kamijo A, Kimura K, Sugaya T, Yamanouchi M, Hikawa A, Hirano N, et al. Urinary fatty acid-binding protein as a new clinical marker of the progression of chronic renal disease. J Lab Clin Med 2004;143:23-30.
12. Kamijo A, Sugaya T, Hikawa A, Okada M, Okumura F, Yamanouchi M, et al. Urinary excretion of fatty acid-binding protein reflects stress overload on the proximal tubules. Am J Pathol 2004;165:1243-55.
13. Nakamura T, Sugaya T, Node K, Ueda Y, Koide H. Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy. Am J Kidney Dis 2006;47:439-44.
14. World Health Organization. Nutritional anemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser 1968;405:5-37.
15. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, et al. Acute Kidney Injury Network. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007;11:R31.
16. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009;53:982-92.
17. Sheridan AM, Schwartz JH, Kroshian VM, Tercyak AM, Laraia J, Masino S, et al. Renal mouse proximal tubular cells are more susceptible than MDCK cells to chemical anoxia. Am J Physiol 1993;265:F342-50.
18. Kees-Folts D, Sadow JL, Schreiner CF. Tubular catabolism of albumin is associated with the release of an inflammatory lipid. Kidney Int 1994;45:1697-709.
19. Kamijo A, Kimura K, Sugaya T, Yamanouchi M, Hase H, Kaneko T, et al. Urinary free fatty acids bound to albumin aggravate tubulointerstitial damage. Kidney Int 2002;62:1628-37.
20. Yokoyama T, Noiri E, Ono Y, Doi K, Negishi, Kamijo A. Renal L-type fatty acid?binding protein in acute ischemic injury. J Am Soc Nephrol 2007;18:2894-902.
21. Fine LG, Bandyopadhay D, Norman JT. Is there a common mechanism for the progression of different types of renal diseases other than proteinuria? Towards the unifying theme of chronic hypoxia Kidney Int 2000;75:S22-6.
22. Kamijo-Ikemori A, Sugaya T, Kimura K. Urinary fatty acid binding protein in renal disease. Clin Chim Acta 2006;374:1-7.
23. McCullough PA, Adam A, Becker CR, Davidson C, Lameire N, Stacul F, et al. Risk prediction of contrast-induced nephropathy. Am J Cardiol 2006;98:27K-36K.
24. Maeder M, Klein M, Fehr T, Rickli H. Contrast nephropathy: review focusing on prevention. J Am Coll Cardiol 2004;44:1763-71.
25. Lassnigg A, Schmidlin D, Mouhieddine M, Bachmann LM, Druml W, Bauer P, et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol 2004;15:1597-605.
26. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW. Acute renal failure after coronary intervention: incidence, risk factors and relationship to mortality. Am J Med 1997;103:368-75.